Invesaro

Stocks SIF Financial statements

Financial statements

SIFCO INDUSTRIES INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data SIFCO INDUSTRIES INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue11912111111211499.683.966.179.684.8
Cost of revenue10710810110293.688.485.862.773.774.2
Gross profit12.113.410.110.62011.2-1.863.355.9810.6
Research and development000000
Selling, general and administrative17.417.815.215.31413.511.912.311.110.4
Operating income-12.1-11.5-5.91-7.0410.1-1.1-14.1-9-5.150.18
Interest expense1.722.212.141.050.890.640.651.353.081.69
Interest income0.050.060.010
Other non-operating income0.430.590.4-0.12-0.23-0.49-0.06-0.5-0.360.54
Pre-tax income-13.3-13.1-7.53-8.218.98-1.97-9.68-10.5-8.59-0.75
Income tax-21.07-0.36-0.7-0.21-1.22-0.040.020.040.19
Income from continuing operations-11.3-10.5-8.63-0.93
Net income-11.3-14.2-7.17-7.519.19-0.74-9.64-8.69-5.38-0.73
EBITDA-1.3-1.552.550.4817.56.56-7.72-3.93-0.375.2
EPS, basic-2.07-2.59-1.30-1.351.62-0.13-1.65-1.47-0.90-0.12
EPS, diluted-2.07-2.59-1.30-1.351.59-0.13-1.65-1.47-0.90-0.12
Shares, basic (weighted)5.485.495.525.575.665.765.835.9366.06
Shares, diluted (weighted)5.485.495.525.575.795.765.835.9366.06

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents0.471.41.250.340.430.351.170.021.710.49
Short-term investments0
Receivables25.225.92823.223.219.916.515.617.316.1
Inventory28.520.418.310.515.612.58.974.556.234.19
Other current assets2.181.641.91.462.341.791.851.552.42.19
Total current assets58.152.149.649.555.247.638.841.554.335.1
Property, plant and equipment4939.535.439.644.242.739.329.526.321.8
Lease right-of-use assets01715.915.214.213.312.5
Goodwill11.712.2123.493.493.493.493.493.493.49
Intangible assets11.16.815.083.321.890.870.480.28
Other non-current assets0.540.260.170.220.140.080.080.370.360.47
Total assets13011110296.112211197.396.310573.4
Accounts payable14.512.815.519.8149.8110.41111.65.8
Accrued liabilities5.236.795.115.568.296.875.873.344.623.14
Deferred revenue00.380.640.240.150.732.881.78
Short-term debt317.565.945.797.149.574.3816.72410.6
Total current liabilities50.845.747.846.743.33632.641.25422.2
Long-term debt7.625.152.332.054.612.673.51000.05
Lease liabilities016.215.414.813.91312.2
Other non-current liabilities0.430.430.150.060.770.740.740.660.650.62
Total liabilities70.160.8586076.46156.661.974.236.5
Total debt34.97.943.5523.424.621.219.122.62410.6
Paid-in capital9.229.521010.410.711.111.411.611.811.9
Retained earnings58.544.337.133.142.341.63223.317.917.2
Other comprehensive income-12.9-9.25-8.63-13.3-13.5-9.08-8.69-6.66-5.391.66
Shareholders' equity60.450.144.236.145.549.640.734.330.436.9
Total equity60.450.144.236.145.549.640.734.330.436.9
Total liabilities and equity13011110296.112211197.396.310573.4
Shares outstanding5.535.65.695.785.925.996.046.116.166.18

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income-11.3-14.2-7.17-7.519.19-0.74-9.64-8.69-5.38-0.73
Depreciation and amortization10.89.998.467.537.387.666.355.074.785.02
Deferred income tax0.710.19-0.82-0.57-0.42-1.29-0.050.010.010.01
Change in receivables10.9-0.29-2.164.51
Change in inventory-0.318.091.481.03-4.651.950.442.62-2.97-1.38
Change in payables0.42-2.322.712.05-7.06-4.440.813.31.46-6.05
Cash from operations12.3121.35.730.453.890.3-1.36-2.650.13
Capital expenditures-2.35-2.34-2.83-9.45-9.03-4.98-3.2-1.12-1.99-0.48
Acquisitions0.280
Cash from investing-2.07-2.270.69-0.77-1.2-0.88-3.19-2.43-1.99-0.48
Debt issued01.221.516.6302.25030
Debt repaid-14.3-5.51-1.42-1.62-0.41-1.24-0.24-0.06
Share buybacks0-0.060
Dividends paid0
Cash from financing-10.4-8.8-2.1-5.870.82-3.113.732.886.33-14
Exchange rate effect0.020-0.03-00.010.02-0.010.11
Net change in cash-0.12-0.910.07-0.10.84-0.812.360.33
Free cash flow9.939.66-1.54-3.72-8.58-1.09-2.9-2.48-4.64-0.36
Interest paid1.421.561.420.950.690.40.590.991.471.87
Income taxes paid2.91.340.10.120.050.060.020.010.020.02

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $22.06 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin16.6%Gross profit / revenue.
Operating margin5.2%Operating income / revenue.
EBITDA margin9.4%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin4.1%Pre-tax income / revenue.
Net margin4.0%Net income / revenue.
FCF margin3.4%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin4.1%Cash from operations / revenue.
Effective tax rate4.5%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)9.6%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)5.0%Net income / average total assets.
Return on invested capital (ROIC)10.1%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue11.4%Selling, general and administrative expense / revenue.
Capex / revenue0.7%Capital expenditures / revenue.
D&A / revenue4.3%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y6.5%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y0.4%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y-5.7%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y76.9%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 5y-11.9%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income CAGR, 5y-55.4%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA CAGR, 5y-21.6%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow CAGR, 3y-24.7%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y-22.3%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y21.2%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-3.2%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y-4.1%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y-29.8%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-9.0%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-9.7%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y1.0%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y1.3%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y0.9%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.77xCurrent assets / current liabilities.
Quick ratio0.76x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.00x(Cash + short-term investments) / current liabilities.
Debt / equity0.17xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets8.8%Total debt / total assets.
Liabilities / assets48.1%Total liabilities / total assets.
Net debt$7.0MTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA0.74xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage3.82xOperating income / interest expense.
Working capital$19.5MCurrent assets - current liabilities.
Goodwill and intangibles / assets4.4%(Goodwill + intangible assets) / total assets.
Tangible book value$38.0MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover1.24xRevenue / average total assets.
Fixed asset turnover5.13xRevenue / average property, plant and equipment.
Inventory turnover8.24xCost of revenue / average inventory.
Days inventory44 days365 x average inventory / cost of revenue.
Receivables turnover5.19xRevenue / average receivables.
Days sales outstanding70 days365 x average receivables / revenue.
Days payables41 days365 x average accounts payable / cost of revenue.
Cash conversion cycle73 daysDays inventory + days sales outstanding - days payables.
FCF conversion85.2%Free cash flow / net income, when net income is positive.
Capex / operating cash flow17.3%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$0.65Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$16.21Revenue / diluted weighted shares.
FCF per share$0.55Free cash flow / diluted weighted shares.
Operating cash flow per share$0.67Cash from operations / diluted weighted shares.
Book value per share$6.64Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$6.08Tangible book value / shares outstanding.
Cash per share$0.01(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$138.0MShare price x shares outstanding.
Enterprise value$144.9MMarket cap + total debt - cash - short-term investments.
P/E34.7xMarket cap / net income. Only when net income is positive.
P/S1.39xMarket cap / revenue.
P/B3.32xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book3.63xMarket cap / tangible book value, when positive.
P/FCF40.8xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF33.7xMarket cap / cash from operations, when positive.
EV/Sales1.46xEnterprise value / revenue.
EV/EBIT28.3xEnterprise value / operating income, when both are positive.
EV/EBITDA15.5xEnterprise value / EBITDA, when both are positive.
EV/FCF42.8xEnterprise value / free cash flow, when both are positive.
FCF yield2.5%Free cash flow / market cap.
Earnings yield2.9%Net income / market cap (the inverse of P/E).
What was SIFCO INDUSTRIES INC's revenue in fiscal 2025?

SIFCO INDUSTRIES INC reported revenue of $84.8M for fiscal 2025, 6.5% higher than the year before.

Was SIFCO INDUSTRIES INC profitable in fiscal 2025?

No. It reported a net loss of $729.0K.

How much free cash flow did SIFCO INDUSTRIES INC generate in fiscal 2025?

Cash from operations of $127.0K minus capital expenditures of $484.0K left free cash flow of -$357.0K.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to SIFCO INDUSTRIES INC